SEI Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,738
Closed -$131K 3966
2018
Q1
$131K Buy
6,738
+1,257
+23% +$24.7K ﹤0.01% 2040
2017
Q4
$91K Buy
5,481
+1,236
+29% +$22.7K ﹤0.01% 2179
2017
Q3
$86K Buy
4,245
+372
+10% +$7.11K ﹤0.01% 2128
2017
Q2
$62K Buy
3,873
+978
+34% +$14.4K ﹤0.01% 2203
2017
Q1
$37K Sell
2,895
-82,148
-97% -$992K ﹤0.01% 2208
2016
Q4
$1.13M Hold
85,043
0.01% 1331
2016
Q3
$2.02M Buy
85,043
+13,323
+19% +$358K 0.01% 1077
2016
Q2
$2.07M Buy
71,720
+2,764
+4% +$90.1K 0.01% 990
2016
Q1
$2.21M Buy
68,956
+68,392
+12,126% +$2.4M 0.01% 938
2015
Q4
$24K Sell
564
-18,481
-97% -$738K ﹤0.01% 2068
2015
Q3
$671K Buy
+19,045
New +$858K 0.01% 1179

SEI Investments's IPXL Position: Q2 2018 in Review

SEI Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 6,738 shares — an estimated $131K sold.

SEI Investments first reported a position in IPXL in Q3 2015 and held it in 11 quarters. The position peaked at $2.21M in Q1 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • SEI Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • SEI Investments sold 6,738 Impax Laboratories, Inc. shares in Q2 2018, an estimated $131K.
  • SEI Investments first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 11 quarters.
  • SEI Investments's Impax Laboratories, Inc. position peaked at $2.21M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on SEI Investments's 13F filing for Q2 2018, filed 3 Aug 2018.